BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vos-Geelen J, Geurts SM, van Putten M, Valkenburg-van Iersel LB, Grabsch HI, Haj Mohammad N, Hoebers FJ, Hoge CV, Jeene PM, de Jong EJ, van Laarhoven HW, Rozema T, Slingerland M, Tjan-Heijnen VC, Nieuwenhuijzen GA, Lemmens VE. Trends in treatment and overall survival among patients with proximal esophageal cancer. World J Gastroenterol 2019; 25(47): 6835-6846 [PMID: 31885424 DOI: 10.3748/wjg.v25.i47.6835] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Xu C, Wang H, Song T, Wu S, Liang X, Xu H. Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma. Front Med (Lausanne) 2021;8:714619. [PMID: 34631736 DOI: 10.3389/fmed.2021.714619] [Reference Citation Analysis]
2 Butt WT, Reynolds JV. Isolated oesophageal adenocarcinoma metastasis at percutaneous endoscopic gastrostomy (PEG) site. BMJ Case Rep 2020;13:e236778. [PMID: 32606109 DOI: 10.1136/bcr-2020-236778] [Reference Citation Analysis]
3 Hulshof MCCM, Geijsen ED, Rozema T, Oppedijk V, Buijsen J, Neelis KJ, Nuyttens JJME, van der Sangen MJC, Jeene PM, Reinders JG, van Berge Henegouwen MI, Thano A, van Hooft JE, van Laarhoven HWM, van der Gaast A. Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study). J Clin Oncol 2021;39:2816-24. [PMID: 34101496 DOI: 10.1200/JCO.20.03697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu G, Song J, Zhao Y, Zhang L, Qin J, Cui Y. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway. J Recept Signal Transduct Res 2020;40:471-8. [PMID: 32340525 DOI: 10.1080/10799893.2020.1756327] [Reference Citation Analysis]
5 de Vos-Geelen J, Geurts SME, Nieuwenhuijzen GAP, Voncken FEM, Bogers JA, Braam PM, Muijs CT, de Jong MA, Kasperts N, Rozema T, Blom GJ, Bouwense SAW, Valkenburg-van Iersel LBJ, Jeene PM, Hoebers FJP, Tjan-Heijnen VCG. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer. Eur J Surg Oncol 2021;47:2016-22. [PMID: 33583629 DOI: 10.1016/j.ejso.2021.02.001] [Reference Citation Analysis]
6 Liu Z, Zhao C, Du S, Gao S, Lu L. MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level. Exp Mol Pathol 2020;115:104476. [PMID: 32473153 DOI: 10.1016/j.yexmp.2020.104476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]